Stifel analyst Justin Keywood lowered the firm’s price target on Andlauer Healthcare to C$50 from C$52 and keeps a Buy rating on the shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ANDHF:
Questions or Comments about the article? Write to editor@tipranks.com